Allurion Technologies

Allurion Technologies, Inc. is a biotechnology and pharmaceutical company focused on innovative solutions for obesity. Founded in 2009 and headquartered in Natick, Massachusetts, Allurion operates globally, including in Spain, France, and Turkey. The company aims to create a comprehensive weight loss platform to help individuals achieve significant weight loss and improve their health. One of its key offerings is the Allurion Balloon, a swallowable intragastric balloon that provides a minimally invasive weight loss option. Clinical evidence shows that patients can lose 10–15% of their body weight within 16 weeks. The Allurion Program combines the balloon with artificial intelligence-powered remote monitoring tools, a behavior change program, and telehealth services, providing a holistic approach to weight management. Allurion Technologies employs around 137 people and is recognized as a great workplace. The company is listed on the New York Stock Exchange under the ticker symbol ALUR, and it operates with a mission to enhance the quality of life for individuals seeking effective weight loss solutions.